{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,25]],"date-time":"2026-06-25T04:39:19Z","timestamp":1782362359074,"version":"3.54.5"},"reference-count":16,"publisher":"American Medical Association (AMA)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Neurol"],"published-print":{"date-parts":[[2021,6,1]]},"DOI":"10.1001\/jamaneurol.2021.0627","type":"journal-article","created":{"date-parts":[[2021,3,16]],"date-time":"2021-03-16T19:59:19Z","timestamp":1615924759000},"page":"736","source":"Crossref","is-referenced-by-count":59,"title":["Progressive Multifocal Leukoencephalopathy in a Patient With Progressive Multiple Sclerosis Treated With Ocrelizumab Monotherapy"],"prefix":"10.1001","volume":"78","author":[{"given":"Arpan","family":"Patel","sequence":"first","affiliation":[{"name":"Department of Neurology, North Shore University Hospital, Donald and Barbara Zucker School of Medicine at Hofstra\/Northwell, Great Neck, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James","family":"Sul","sequence":"additional","affiliation":[{"name":"Department of Neurology, North Shore University Hospital, Donald and Barbara Zucker School of Medicine at Hofstra\/Northwell, Great Neck, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc L.","family":"Gordon","sequence":"additional","affiliation":[{"name":"Department of Neurology, North Shore University Hospital, Donald and Barbara Zucker School of Medicine at Hofstra\/Northwell, Feinstein Institutes for Medical Research, Manhasset, New York"},{"name":"Department of Psychiatry, North Shore University Hospital, Donald and Barbara Zucker School of Medicine at Hofstra\/Northwell, Feinstein Institutes for Medical Research, Manhasset, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jared","family":"Steinklein","sequence":"additional","affiliation":[{"name":"Division of Neuroradiology, Department of Radiology, Lenox Hill Hospital, Donald and Barbara Zucker School of Medicine at Hofstra\/Northwell, New York, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shayna","family":"Sanguinetti","sequence":"additional","affiliation":[{"name":"Department of Neurology, North Shore University Hospital, Donald and Barbara Zucker School of Medicine at Hofstra\/Northwell, Great Neck, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bidyut","family":"Pramanik","sequence":"additional","affiliation":[{"name":"Division of Neuroradiology, Department of Radiology, Lenox Hill Hospital, Donald and Barbara Zucker School of Medicine at Hofstra\/Northwell, New York, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dushyant","family":"Purohit","sequence":"additional","affiliation":[{"name":"Department of Pathology, Mount Sinai Medical Center, Mount Sinai School of Medicine, New York, New York"},{"name":"Department of Psychiatry, Mount Sinai Medical Center, Mount Sinai School of Medicine, New York, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vahram","family":"Haroutunian","sequence":"additional","affiliation":[{"name":"Department of Psychiatry, Mount Sinai Medical Center, Mount Sinai School of Medicine, New York, New York"},{"name":"MIRECC, JJ Peters VA Medical Center, Bronx, New York"},{"name":"Department of Neuroscience, Mount Sinai Medical Center, Mount Sinai School of Medicine, New York, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alex","family":"Williamson","sequence":"additional","affiliation":[{"name":"Department of Pathology & Laboratory Medicine, LIJ Medical Center, Donald and Barbara Zucker School of Medicine at Hofstra\/Northwell, New Hyde Park, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Igor","family":"Koralnik","sequence":"additional","affiliation":[{"name":"Department of Neurology, Northwestern University, Feinberg School of Medicine, Chicago, Illinois"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Asaff","family":"Harel","sequence":"additional","affiliation":[{"name":"Division of Neuro-Immunology, Department of Neurology, Lenox Hill Hospital, North Shore University Hospital, Zucker School of Medicine at Hofstra\/Northwell, New York, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","reference":[{"issue":"3","key":"nbr210001r1","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1136\/jnnp.2009.187666","article-title":"Progressive multifocal leukoencephalopathy in individuals with minimal or occult immunosuppression.","volume":"81","author":"Gheuens","year":"2010","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"6","key":"nbr210001r2","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1177\/1756285615602832","article-title":"Progressive multifocal leukoencephalopathy: current treatment options and future perspectives.","volume":"8","author":"Pavlovic","year":"2015","journal-title":"Ther Adv Neurol Disord"},{"issue":"3","key":"nbr210001r3","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1007\/s13365-018-0615-7","article-title":"Progressive multifocal leukoencephalopathy in rituximab-treated rheumatic diseases: a rare event.","volume":"24","author":"Berger","year":"2018","journal-title":"J Neurovirol"},{"issue":"17","key":"nbr210001r4","doi-asserted-by":"publisher","first-page":"1597","DOI":"10.1056\/NEJMoa1815039","article-title":"Pembrolizumab treatment for progressive multifocal leukoencephalopathy.","volume":"380","author":"Cortese","year":"2019","journal-title":"N Engl J Med"},{"issue":"5","key":"nbr210001r6","doi-asserted-by":"publisher","first-page":"742","DOI":"10.1007\/s13365-017-0561-9","article-title":"Age as a risk factor for early onset of natalizumab-related progressive multifocal leukoencephalopathy.","volume":"23","author":"Prosperini","year":"2017","journal-title":"J Neurovirol"},{"issue":"20","key":"nbr210001r7","doi-asserted-by":"publisher","first-page":"e1815","DOI":"10.1212\/WNL.0000000000005529","article-title":"Progressive multifocal leukoencephalopathy after fingolimod treatment.","volume":"90","author":"Berger","year":"2018","journal-title":"Neurology"},{"key":"nbr210001r8","doi-asserted-by":"crossref","DOI":"10.1177\/1352458520949158","article-title":"Progressive multifocal leukoencephalopathy in dimethyl fumarate-treated multiple sclerosis patients.","author":"Jordan","year":"2020","journal-title":"Mult Scler"},{"issue":"2","key":"nbr210001r9","first-page":"133","article-title":"Progressive multifocal leukoencephalopathy in elderly immunocompetent patients: report of 2 cases [in Spanish].","volume":"29","author":"Bosch","year":"1999","journal-title":"Rev Neurol"},{"issue":"3","key":"nbr210001r10","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1111\/tan.2007.70.issue-3","article-title":"Immunosenescence: deficits in adaptive immunity in the elderly.","volume":"70","author":"Hakim","year":"2007","journal-title":"Tissue Antigens"},{"issue":"3","key":"nbr210001r11","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1056\/NEJMoa1601277","article-title":"Ocrelizumab versus interferon beta-1a in relapsing multiple sclerosis.","volume":"376","author":"Hauser","year":"2017","journal-title":"N Engl J Med"},{"issue":"3","key":"nbr210001r12","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1056\/NEJMoa1606468","article-title":"Ocrelizumab versus placebo in primary progressive multiple sclerosis.","volume":"376","author":"Montalban","year":"2017","journal-title":"N Engl J Med"},{"issue":"6","key":"nbr210001r13","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1097\/JNN.0000000000000172","article-title":"The elderly person with multiple sclerosis: clinical implications for the increasing life-span.","volume":"47","author":"Buhse","year":"2015","journal-title":"J Neurosci Nurs"},{"issue":"23","key":"nbr210001r14","doi-asserted-by":"publisher","first-page":"1996","DOI":"10.1212\/WNL.0b013e3181c5b47f","article-title":"The natural history of primary progressive multiple sclerosis.","volume":"73","author":"Koch","year":"2009","journal-title":"Neurology"},{"issue":"1","key":"nbr210001r16","doi-asserted-by":"publisher","first-page":"8","DOI":"10.3390\/cells8010012","article-title":"Ocrelizumab depletes CD20+ T cells in multiple sclerosis patients.","volume":"8","author":"Gingele","year":"2018","journal-title":"Cells"},{"key":"nbr210001r15"},{"key":"nbr210001r5","unstructured":"Genentech. Ocrelizumab & PML: prescribing information. Accessed August 2, 2020. https:\/\/www.ocrelizumabinfo.com\/content\/dam\/gene\/ocrelizumabinfo\/pdfs\/progressive-multifocal-leukoencephalopathy.pdf"}],"container-title":["JAMA Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamaneurology\/articlepdf\/2777642\/jamaneurology_patel_2021_br_210001_1622672687.24783.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,6,10]],"date-time":"2021-06-10T15:42:49Z","timestamp":1623339769000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamaneurology\/fullarticle\/2777642"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6,1]]},"references-count":16,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2021,6,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamaneurol.2021.0627","relation":{},"ISSN":["2168-6149"],"issn-type":[{"value":"2168-6149","type":"print"}],"subject":[],"published":{"date-parts":[[2021,6,1]]}}}